ApoM promotes the formation of pre–β-HDL from α-HDL, and lower levels of ApoM may explain why pre-β-HDL formation is not increased in type 2 diabetes, despite increased PLTP activity. Here, PLTP is linked to type 2 diabetes mellitus.